Learn More
Enzo Life Sciences BML-288 (25mg)

Supplier: Enzo Life Sciences BMLPD2000025
Potent (IC50=40nM) and selective (290X selectivity over other PDE isoforms) inhibitor of phosphodiesterase Type II (PDE2). Displayed no significant level of binding to neither a collection of 54 receptors and ion channels, nor to a panel of 30 kinases. BML-288 demonstrated no inhibition of 5-lipoxygenase (5-LO) or cyclooxygenase (COX-1). BML-288 is more potent and selective than EHNA (BML-PD129). Alternative name: 5-Methyl-6-oxo-N-(1,3,4-thiadiazol-2-yl)-7H-furo[2,3-f]indole-7-carboxamide. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (25 mg/ml). Long Term Storage: -20°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.